Lung Cancers Terminated Phase 2 / 3 Trials for Pazopanib (DB06589)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01208064Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line ChemotherapyTreatment